Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein-2 in Multilevel Posterolateral Lumbar Fusion in a Prospective, Randomized, Controlled Trial.
Neurospine
; 19(3): 838-846, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-36203306
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Aspects:
Patient_preference
Language:
En
Journal:
Neurospine
Year:
2022
Document type:
Article
Country of publication: